Telmikind AMH Tablet 10s

Telmikind Amh Tablet 10s is a powerful triple-combination antihypertensive medication containing Amlodipine (a calcium channel blocker), Hydrochlorothiazide (a diuretic), and Telmisartan (an angiotensin II receptor blocker). This "3-in-1" therapy is specifically designed for patients whose blood pressure is not sufficiently controlled by dual therapy. By targeting three different physiological pathways, it effectively relaxes blood vessels and removes excess fluid to significantly lower blood pressure and reduce the risk of heart attack and stroke.

Telmikind Amh Tablet 10s is a fixed-dose combination medication containing Amlodipine, Hydrochlorothiazide, and Telmisartan, used to manage high blood pressure (hypertension) in adults. This combination works through three complementary mechanisms to provide effective and comprehensive blood pressure control.

Amlodipine is a calcium channel blocker that relaxes blood vessels, reducing resistance and making it easier for the heart to pump blood. Hydrochlorothiazide is a thiazide diuretic that helps the body eliminate excess salt and water, reducing blood volume and lowering blood pressure. Telmisartan is an angiotensin II receptor blocker (ARB) that prevents blood vessels from constricting and protects the heart and kidneys from the effects of high blood pressure.

By combining these three agents, Telmikind Amh Tablet 10s targets multiple pathways that contribute to hypertension, helping to achieve better blood pressure control than monotherapy alone. It is typically prescribed for adults who require more than one medication to reach their target blood pressure or who have risk factors for cardiovascular complications.

Patients taking Telmikind Amh Tablet 10s should follow their healthcare provider’s instructions carefully, including regular blood pressure monitoring, lifestyle modifications, and adherence to diet and exercise recommendations, to maximise effectiveness and reduce the risk of side effects.

Telmikind Amh Tablet 10s is indicated for:

Resistant Hypertension:

Treatment of high blood pressure in patients not adequately controlled on a combination of any two of these classes.

Step-up Therapy:

As a replacement for individual tablets of Telmisartan, Amlodipine, and HCTZ for patients already stabilised on these doses.

Cardiovascular Protection:

Long-term reduction of the risk of fatal and non-fatal cardiovascular events, primarily stroke and myocardial infarction.

Superior BP Lowering:

Achieves greater blood pressure reduction than single or dual-agent combinations.

Simplified Regimen:

Replaces three separate pills with one, significantly increasing the likelihood that patients will take their medication correctly.

Reduced Side Effects:

Using lower doses of three different drugs can sometimes lead to fewer side effects than using a very high dose of a single drug.

Organ Protection:

Helps protect the kidneys and heart from the long-term damaging effects of high pressure.

Most side effects are manageable and may decrease as your body adjusts to the triple combination.

Common side effects:

• Dizziness or lightheadedness (especially when standing up)

• Peripheral oedema (swelling of ankles or feet)

• Fatigue or tiredness

• Nausea

• Increased frequency of urination (due to the diuretic)

• Changes in electrolyte levels (e.g., low potassium)

Less common side effects:

• Upper respiratory tract infection

• Back pain or muscle cramps

• Diarrhea

• Skin rash

Rare but serious side effects (seek medical attention immediately):

• Angioedema: Swelling of the face, lips, tongue, or throat.

• Kidney Dysfunction: Significant decrease in urination or swelling in the face/eyes.

• Electrolyte Imbalance: Severe muscle weakness, irregular heartbeat, or extreme thirst.

• Hypotension: Fainting or severe lightheadedness.

• Timing: Take the tablet once daily, preferably in the morning, to avoid waking up at night to urinate.
• Consistency: Take it at the same time every day with or without food.
• Swallow Whole: Do not crush or chew the tablet.
• Hydration: While the medicine helps remove excess water, you should still maintain healthy, normal fluid intake unless told otherwise by a doctor.
• Monitoring: Regular blood pressure checks at home are recommended to track progress.

Telmikind Amh Tablet 10s is a fixed-dose triple-combination antihypertensive that effectively lowers blood pressure by acting on multiple physiological pathways.

• Amlodipine, a calcium channel blocker, inhibits calcium influx into the smooth muscle cells of blood vessels, promoting relaxation and vasodilation. This decreases peripheral vascular resistance, allowing the heart to pump blood more efficiently.

• Hydrochlorothiazide, a thiazide diuretic, enhances renal excretion of sodium and water. This reduces circulating blood volume, decreasing cardiac workload and contributing to sustained blood pressure reduction.

• Telmisartan, an angiotensin II receptor blocker (ARB), selectively blocks angiotensin II receptors, preventing vasoconstriction and reducing aldosterone-mediated sodium and water retention. This not only lowers blood pressure but also protects the cardiovascular and renal systems from the long-term effects of hypertension.

By combining these three agents, Telmikind Amh Tablet 10s addresses vascular tone, fluid balance, and hormonal regulation, offering a comprehensive and synergistic approach to blood pressure management and reducing the risk of cardiovascular and renal complications.

• Morning Dose: Take it in the morning so the diuretic effect (urination) happens during the day rather than at night.

• Hydration: Stay well-hydrated, especially in hot weather or during exercise, to prevent excessive dehydration.

• Dizzy Spells: If you feel dizzy, sit or lie down immediately. This often happens if you are dehydrated or stand up too quickly.

• Lab Tests: Expect your doctor to order blood tests periodically to check your kidney function and electrolyte (potassium, sodium) levels.

Store at room temperature (15-30°C) in a dry place. Protect from light and moisture. Keep the tablets in their original container until use.

• Potassium Supplements / Salt Substitutes: Telmisartan can increase potassium levels. Using potassium-rich salt substitutes can lead to dangerously high potassium (hyperkalemia).

• Grapefruit Juice: May increase the concentration of Amlodipine in the blood.

• Lithium: HCTZ and Telmisartan can increase lithium levels to toxic amounts.
• NSAIDs (e.g., Aspirin, Naproxen): Can reduce the antihypertensive effect and increase the risk of kidney damage.
• Other Diuretics: May cause excessive fluid loss and very low blood pressure.
• Digoxin: Telmisartan may increase the concentration of digoxin in the blood.

• Diabetes: HCTZ may affect glucose tolerance; Telmisartan may mask symptoms of hypoglycemia.
• Gout: HCTZ can increase uric acid levels, potentially triggering a gout attack.
• Lupus: Thiazide diuretics have been known to activate or exacerbate systemic lupus erythematosus.
• Renal Artery Stenosis: Use with extreme caution as it may lead to acute renal failure.

The typical dose is one tablet taken once daily. Dosage should be individualised by a physician.

Overdose may cause severe hypotension, electrolyte imbalance, and dehydration. Symptoms include extreme dizziness, fast or slow heart rate, and fainting. Contact emergency services or a poison control centre immediately.

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not take two doses at once.